Top Nav

Model N, Tetraphase IPOs Debut

Ian Wyatt

Two IPOs hit the market today – with two very different first-day performances.

Model N (NYSE: MODN), a provider of revenue management software to the life science and technology sectors, was up 28% in its debut despite pricing above its expected range. The stock went public at $15.50 a share, ahead of its predicted $12.50-$14.50 range. But that didn’t stop it from rising all the way to $19.84 on Wednesday.

Tetraphase Pharmaceutical’s (NASDAQ: TTPH) IPO wasn’t quite as effective.

A developer of antibiotics that treat serious abdominal and urinary tract infections, Tetraphase shares priced at $7 a share – well below the $10 to $12 range listed in the company’s original IPO filing. The stock didn’t budge from there, finishing at exactly $7 after rising as high as $7.50.

Six more companies are scheduled to go public in the coming days, including another pharmaceutical company called Enanta. Tetraphase’s first-day struggles likely have Enanta officials a bit more apprehensive about their company’s IPO.

On the flip side, Marin Software is surely encouraged by Model N’s smashing debut. That should embolden the San Francisco-based cloud-computing company ahead of its IPO, which could come by week’s end.

Model N and Tetraphase were just the fourth and fifth companies to go public this month.

Income and Prosperity Offer

Income & Prosperity is designed to help you seek out the safest income opportunities and discover an entire world of dividend investments. This free newsletter has a laser-like focus on one issue and one issue only: how can investors near or in retirement generate more income. Each day, you'll receive our best investment idea - skewed towards safe income - but also including lesser known opportunities to grow your wealth while keeping it out of harm's way.
You've successfully subscribed, click the link in your email to confirm your subscription.
There was an error, and you have not been subscribed, please try again.